Dr. Grant K. Hunter
Claim this profileUtah Valley Regional Medical Center
Studies Brain Tumor
Studies Gliosarcoma
4 reported clinical trials
9 drugs studied
Area of expertise
1Brain Tumor
IDH positive
1p/19q co-deletion positive
1p/19q loss positive
2Gliosarcoma
IDH negative
MET positive
MET negative
Affiliated Hospitals
Clinical Trials Grant K. Hunter is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Radiation Therapy vs Observation
for Meningioma
This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.
Recruiting2 awards Phase 312 criteria
More about Grant K. Hunter
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Grant K. Hunter has experience with
- Radiation Therapy
- Temozolomide
- Clinical Observation
- Radiotherapy
- CCNU
- Ipilimumab
Breakdown of trials Grant K. Hunter has run
Brain Tumor
Gliosarcoma
Glioblastoma
Central Nervous System Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Grant K. Hunter specialize in?
Grant K. Hunter focuses on Brain Tumor and Gliosarcoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Grant K. Hunter currently recruiting for clinical trials?
Yes, Grant K. Hunter is currently recruiting for 2 clinical trials in Provo Utah. If you're interested in participating, you should apply.
Are there any treatments that Grant K. Hunter has studied deeply?
Yes, Grant K. Hunter has studied treatments such as Radiation Therapy, Temozolomide, Clinical Observation.
What is the best way to schedule an appointment with Grant K. Hunter?
Apply for one of the trials that Grant K. Hunter is conducting.
What is the office address of Grant K. Hunter?
The office of Grant K. Hunter is located at: Utah Valley Regional Medical Center, Provo, Utah 84604 United States. This is the address for their practice at the Utah Valley Regional Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.